BCTXLBriaCell Therapeutics Corp.vs its industry peers
A metric-by-metric comparison of BriaCell Therapeutics Corp. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCTXLEsta | $9M#6 | — | — | — | — | -449.1%#6 | — | — | — | — | — | — |
| ASND | $16.1B#1 | — | — | — | — | — | — | — | — | — | — | — |
| ATHE | $974M#3 | — | — | — | — | — | — | — | — | — | — | — |
| AUPH | $2.1B#2 | 7.0x#1 | 3.5x#2 | 7.5x#2 | 20.4%#5 | 4851.7%#1 | 37.1%#1 | 46.7%#1 | — | — | 37.0%#1 | — |
| AXIM | — | — | — | — | 434.2%#1 | -191.7%#5 | -6961.0%#6 | — | — | — | — | — |
| AZN | — | — | — | — | 8.6%#6 | 45.3%#3 | 23.4%#2 | 21.0%#2 | — | — | — | — |
| BCTX | $31M#5 | — | — | — | — | -449.1%#6 | — | — | — | — | — | — |
| BCTXZ | $1M#7 | — | — | — | — | -449.1%#6 | — | — | — | — | — | — |
| BEIGF | — | — | — | — | 40.2%#3 | 144.5%#2 | 8.4%#3 | 5.5%#3 | 29.9%#1 | 6#1 | — | — |
| BGM | — | — | — | — | 51.1%#2 | -1282.1%#9 | -33.2%#5 | -5.1%#4 | — | — | — | — |
| BHST | $42M#4 | — | 1.7x#1 | 1.2x#1 | 37.0%#4 | 13.8%#4 | -16.2%#4 | -43.8%#5 | -216.8%#2 | — | -79.6%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice